5896 J . Org. Chem., Vol. 65, No. 19, 2000
Sundaram and Woodard
UV Isom er iza tion of (Z)-[3-F ]-P EP a n d (E)-[3-F ]-P EP
CHA Sa lts. A 60:40 mixture of (Z)-[3-F]-PEP and (E)-[3-F]-
PEP was obtained by irradiating a 0.4 M solution of (Z)-[3-
F]-PEP in D2O (0.5 mL). The solution in a 5 mm quartz NMR
tube (WILMAD) was irradiated at 254 nm at room tempera-
ture, in a Rayonet photochemical reactor for 24 h.3 The
conversion of (Z)-[3-F]-PEP to (E)-[3-F]-PEP was monitored
by 19F NMR. At equilibrium, the solution contained a 60:40
mixture of (Z)-[3-F]-PEP and (E)-[3-F]-PEP, as evidenced by
19F NMR and 1H NMR.
DAH 7-P synthase may have similar binding sites for
both the substrates and some mechanistic commonalties.
The results suggest that if a “carbanion-like species” is
formed at C3 of PEP that attacks the electrophilic C1
aldehyde carbon of the phosphorylated monosaccharide,
as hypothesized earlier by Floss and co-workers for DAH
7-P synthase and by our group for KDO 8-P synthase,
that the lifetime of this anionic species must be shorter
than the time required for the rotation of a methyl group
(<10-10 s). Although it is possible that the free rotation
of the carbanion is significantly restricted in the enzyme
active site, it seems rather unlikely suggesting that
disappearance of the double bond between C2 and C3 of
PEP and formation of a bond between C3 of PEP and C1
of the phosphorylated monosaccharide occur in concert.
Finally, DAH 7-P synthase utilizes both the regioisomers
of [3-F]-PEP at equal rates, unlike KDO 8-P synthase
which exhibits a preference for (E)-[3-F]-PEP over (Z)-
[3-F]-PEP.
(Z)-[3-2H]-P EP a n d (E)-[3-2H]-P EP CHA sa lts. (Z)-[3-2H]-
PEP was prepared as previously reported.49
(E)-[3-2H]-PEP was synthesized by the method reported by
Dotson et al.50 Ethyl bromopyruvate was brominated using
N-bromosuccinimide to give ethyl 3,3-dibromopyruvate, which
upon treatment with trimethyl phosphite under standard
Perkow-type reaction conditions gave a 72:28 mixture of ethyl
(Z)-3-bromo-2-[(dimethoxyphosphinyl)oxy]propenoate and eth-
yl (E)-3-bromo-2-[(dimethoxy-phosphinyl)oxy]propenoate. This
mixture of Z- and E-isomers was treated with tetrakis-
(triphenylphosphine)palladium(0) (1 equiv with respect to the
E-isomer) to give an 80:20 mixture of (E)- and (Z)-[2-
((dimethoxyphosphinyl)oxy)-3-ethoxy-3-oxo-1-propenyl]bromo-
bis(triphenylphosphine)palladium. The E-vinyl palladium com-
plex was separated from the Z-vinyl palladium complex by
flash chromatography on silica gel 60 (230-400 mesh, E.
Merck) using a stepwise gradient of 0, 1, 2, and 3% methanol
in dichloromethane.50
Exp er im en ta l Section
Gen er a l. 1H NMR spectra were acquired on a Bruker
Avance DRX 500 (operating at 500.132 MHz for 1H) with a 5
mm multinuclear inverse gradient probe using the water
suppression program, WATERGATE Gradient Suppression.57
19F NMR spectra were recorded on a Bruker Avance 300
(operating at 282.36 MHz for 19F) and referenced externally
to trifluoroacetic acid (δ ) 0). E 4-P, A 5-P, R 5-P, dR 5-P,
manganese (II) chloride, and trifluoroacetic anhydride were
obtained from Sigma Chemical Co. Bromine and N-bromo-
succinimde were purchased from Fisher Scientific. Cyclohexyl-
amine, diethyl oxalate, ethyl bromopyruvate, ethyl fluoro-
acetate, trimethyl phosphite, and tetrakis(triphenylphos-
phine)palladium(0) were purchased from Aldrich Chemical Co.
Recombinant DAH 7-P synthase (phenylalanine-sensitive) and
KDO 8-P synthase were isolated and purified as previously
reported.52
The purified E-vinyl palladium complex was treated with a
mixture of trifluoroacetic acid-D (99.5 atom % D, Aldrich) and
trifluoroacetic anhydride, under anhydrous conditions to give
ethyl (E)-3-deuterio-2-[(dimethoxyphosphinyl)oxy]propenoate,
which was hydrolyzed using 1 N KOH and immediately loaded
onto a Biorex-70 (BioRad) cation exchange column (1 × 5 cm,
in the proton form). Cyclohexylamine (1 equiv with respect to
the E-vinyl palladium complex) was added to the eluent from
the column, and the mixture was lyophilized to give the CHA
salt of (E)-[3-2H]-PEP.
Gen er a l En zym a tic Syn th esis of [3-2H]-DAH 7-P s a n d
[3-2H]-KDO 8-P An a logu es. To a Chemtube (BioRad, 12 ×
75 mm), containing a solution of 1,3-bis[tris(hydroxymethyl)-
methylamino]propane (BTP) (42.35 mg, 0.15 mmol) and man-
ganese(II) chloride (0.3 mg, 1.5 µmol) in water, was added 13
mg of one of the following monosaccharides, E 4-P (0.044
mmol), A 5-P (0.056 mmol), R 5-P (0.056 mmol), or dR 5-P (0.06
mmol) and 12 mg of either (Z)- or (E)-[3-2H]-PEP CHA salt
(0.044 mmol), and the pH was adjusted to 6.8 using 1 N NaOH.
DAH 7-P synthase (3 mg, 79 nmol) was then added to initiate
the reaction, and the final volume of the reaction mixtures
were made up to 2 mL. Reaction mixtures were incubated at
37 °C for 2 h. The enzymatic reactions were quenched by
adding 0.5 mL of 10% trichloroacetic acid (TCA), vortexed for
30 s, and finally centrifuged for 30 min (1500g) to remove the
precipitated protein. The supernatants were loaded onto 5 mL
Econo-Pac HighQ (BioRad) anion-exchange columns (chloride
form), preequilibrated with water. The columns were washed
(Z)-[3-F ]-P EP Cycloh exyla m m on iu m Sa lt. The title
compound was prepared by the procedure originally reported
by Bergmann and Shahak58 and modified by Stubbe and
Kenyon.1 In brief, diethyl oxalate was treated with sodium
ethyl fluoroacetate to give the sodium enolate of diethyl
fluorooxaloacetate which was directly brominated to give
diethyl bromofluorooxaloacetate. After purification by distil-
lation, the diethyl bromofluorooxaloacetate (86 °C at 0.7
mmHg) was heated at 80 °C for 8 h in concentrated HCl.
Removal of the excess acid in vacuo followed by distillation
gave pure bromofluoropyruvic acid which solidified upon
cooling. The bromofluoropyruvic acid was converted into (Z)-
3-F-2-[(dimethoxyphosphinyl)oxy]propenoic acid under stand-
ard Perkow-type reaction conditions (reaction with trimethyl
phosphite at 0 °C followed by slow warming to room temper-
ature over a 5 h period). This dimethyl ester was hydrolyzed
by dissolving it in water and stirring at room temperature for
8 h. One equivalent of cyclohexylamine was then added, and
the solution was immediately lyophilized to give the mono-
cyclohexylammonium (CHA) salt of (Z)-[3-F]-PEP (92% Z-
with 30 mL of water at
a flow rate of 1 mL/min. The
phosphorylated monosaccharides were eluted from the column
using a linear gradient of 0 to 0.5 M LiCl solution over a period
of 1 h. Fractions containing 3-deuterated DAH 7-P and KDO
8-P analogues, as identified by the thiobarbituric acid as-
say,60,61 were pooled and lyophilized.
1
isomer and 8% E-isomer as determined by H and 19F NMR).
NOTE: the addition of cyclohexylamine to the aqueous solu-
tion of the diester followed by stirring at room temperature,
as in the standard procedure for the preparation of unlabeled
PEP,59 leads to total decomposition.
En zym a tic Syn th esis of (3S)-[3-F ]-DAH 7-P a n d (3R)-
[3-F ]-DAH 7-P . (Z)-[3-F]-PEP or a mixture of (Z)- and (E)-[3-
F]-PEP (60:40) (15 mg, 0.052 mmol) was dissolved in 100 µL
of 0.5 M BTP (pH ) 11.0) in a 1.5 mL microcentrifuge tube.
To these solutions was added 15 mg of E 4-P (0.056 mmol),
and the pH was adjusted to 6.8 using 0.5 M BTP solution (pH
) 11.0). After the addition of 30 µL of 50 mM manganese(II)
chloride (1.5 µmol) solution, 50 µL of D2O was added for
deuterium lock. The reaction mixtures were transferred to
(55) Hansen, P. E. In Annual Reports on NMR Spectroscopy; Webb,
G. A., Ed.; Academic Press: London, 1983; Vol. 15, pp 118-119.
(56) Hansen, P. E. In Progress in NMR Spectroscopy; Pergamon-
Elsevier Science Ltd.: Oxford, U.K., 1988; Vol. 20, pp 207-255.
(57) Piotto, M.; Saudek, V.; Sklenar, V. J . Biomol. NMR 1992, 2,
661-665.
(58) Bergmann, E. D.; Shahak, I. J . Chem. Soc. 1960, 462-463.
(59) Clark, V. M.; Kirby, A. J . Biochim. Biophys. Acta 1963, 78, 732.
(60) Aminoff, D. Biochem. J . 1961, 81, 384-392.
(61) Ray, P. H. J . Bacteriol. 1980, 141, 635-44.